view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
FDA’s Approval of New Alzheimer Drug Raises Many Questions; Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines; Detecting Kids’ Broken Hearts—Cardiac Screening Advised During Well-Child Visits
Related Content:
